// App-Quantinova.ai

1374 : Preclinical investigation of ATR inhibition alone and in combination with PARP inhibition in high risk neuroblastoma

Researchers

Presenter

  • Harriet E. Southgate

Principal Investigators

  • Lindi Chen

  • Nicola J. Curtin

  • Deborah A. Tweddle

Medical Centers

  • Newcastle University, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Neuroblastoma

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

Drug/Treatment

  • Olaparib

  • VE821

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved